Related Experiment Video
Updated: Sep 15, 2025

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
Integrative approaches in Alzheimer's disease: evaluating the potential of traditional, complementary, and
R Sneha Sri1, T Pavithra1, T Vinciya1
1Department of Pharmacology, Dr. M.G.R. Educational and Research Institute, Chennai, Tamil Nadu, India.
Abstract:
This review explores the potential of Traditional, Complementary, and Integrative Medicine (TCIM) as an adjunct to conventional therapies for Alzheimer's Disease (AD). Unlike pharmaceutical treatments that primarily offer symptomatic relief, TCIM encompasses holistic approaches that target multiple pathophysiological pathways involved in AD, including tau pathology, oxidative stress, mitochondrial dysfunction, and neuroinflammation. Herbal therapies such as Withania somnifera, Ginkgo biloba, and Curcuma longa have shown promising neuroprotective effects in preclinical and limited clinical studies. Mind-body practices like Kirtan Kriya meditation have also demonstrated stress-reduction benefits, addressing modifiable risk factors for AD. While current evidence highlights the potential of TCIM interventions to complement standard care, rigorous validation through high-quality randomized controlled trials remains essential. This review underscores the need for integrative, personalized approaches that synergize traditional and modern medical systems to enhance therapeutic outcomes in AD.
More Related Videos
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Dementia
The progression of dementia is generally gradual....